Wealth Building

Showing 1225 articles
Business

Galenica's Five-Year Surge: A 90% Return for Patient Investors

Swiss healthcare group Galenica has delivered robust returns for long-term shareholders, with a total return of 90% over five years, significantly outpacing the broader market. While recent performance has moderated, the stock's journey highlights the value of consistent earnings growth and dividends.

Business

Three Sub-$50 Stocks Investors Should Approach With Caution

While stocks priced between $10 and $50 can appear to offer an attractive balance of accessibility and maturity, not all are sound investments. We examine three companies in this range whose valuations and business prospects raise significant red flags for discerning investors.